Lucius Dacomitinib – Buy Online
Multiple clinical trials have demonstrated that dacomitinib has the potential to prolong progression-free survival (PFS) and overall survival (OS) compared to other EGFR-TKIs. For example, in the ARCHER-1050 clinical study, the median PFS and OS in the dacomitinib group were significantly better than those in the gefitinib group.
View Product